Inari Medical Inc - Company Profile
Powered by 
All the data and insights you need on Inari Medical Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Inari Medical Inc Strategy Report
- Understand Inari Medical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Inari Medical Inc. (Inari) is a medical device company that specializes in developing, manufacturing and commercializing innovative catheter-based technologies for treating venous thromboembolism (VTE). The company products portfolio includes the ClotTriever and FlowTriever systems, which are designed to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari products are used by healthcare professionals, including interventional radiologists, interventional cardiologists and vascular surgeons, in catheterization laboratories and interventional suites. It operates in the US, Switzerland, Singapore, Canada, Australia, Brazil, the UK and Ireland. Inari is headquartered in Irvine, California, the US.
Headquarters
United States of America
Address
6001 Oak Canyon, Suite 100, Irvine, California, 92618
Website
www.inarimedical.com
Telephone
1 949 9234747
No of Employees
1,100
Industry
Medical Equipment
Ticker Symbol & Exchange
NARI (NASD)
Revenue (2022)
$493.6M
28.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
94.4%
(2022 vs 2021)
Market Cap*
$2.4B
Net Profit Margin (2022)
XYZ
95.7%
(2022 vs 2021)
* As of and is in US$
Inari Medical Inc premium industry data and analytics
Products and Services
| Products |
|---|
| ClotTriever System: Deep Vein Thrombosis (DVT) |
| FlowTriever System: Pulmonary Embolism |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company acquired LimFlow. |
| 2021 | Contracts/Agreements | In April, the company and Aidoc entered into a partnership to accelerate the adoption and the clinical impact of AI to treat pulmonary embolism. |
| 2020 | Stock Listings/IPO | In February, the company announced its plans to raise IPO of shares. |
Competitor Comparison
| Key Parameters | Inari Medical Inc | Abbott Laboratories | Boston Scientific Corp | Teleflex Inc | Penumbra Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Irvine | Abbott Park | Marlborough | Wayne | Alameda |
| State/Province | California | Illinois | Massachusetts | Pennsylvania | California |
| No. of Employees | 1,100 | 114,000 | 48,000 | 14,500 | 4,200 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Andrew Hykes | Chief Executive Officer; Director; President | Executive Board | 2023 | 50 |
| Mitchell Hill | Chief Financial Officer | Senior Management | 2019 | 64 |
| Thomas Tu, MD | Chief Medical Officer | Senior Management | 2019 | 50 |
| Vic Tapson, MD | Vice President - Medical Affairs | Senior Management | - | - |
| Paul Koehn | Senior Vice President - Operations | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer